Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00972712|
Recruitment Status : Completed
First Posted : September 7, 2009
Last Update Posted : March 10, 2015
Millennium Pharmaceuticals, Inc.
Ortho Biotech, Inc.
Information provided by (Responsible Party):
Sagar Lonial, Emory University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||March 2015|